Plasma gelsolin as a biomarker of acute rheumatic carditis

Cardiology in the Young

Volumn 25, Issue 7, 2014, Pages 1276-1280

  Argun, Mustafa ^a   Baykan, Ali ^a   Narin, Figen ^a   Özyurt, Abdullah ^a   Pamukçu, Özge ^a   Elmall, Ferhan ^a   Üzüm, Kazlm ^a   Narin, Nazmi ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Acute rheumatic carditis; biomarker; children; gelsolin

Indexed keywords

BIOLOGICAL MARKER; GELSOLIN;

ACUTE DISEASE; ADOLESCENT; BLOOD; CASE CONTROL STUDY; CHILD; COLOR DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HUMAN; MALE; MITRAL VALVE REGURGITATION; MYOCARDITIS; PRESCHOOL CHILD; PROSPECTIVE STUDY; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE;

ACUTE DISEASE; ADOLESCENT; BIOMARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; GELSOLIN; HUMANS; MALE; MITRAL VALVE INSUFFICIENCY; MYOCARDITIS; PROSPECTIVE STUDIES; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE;

EID: 84941118611     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951114002327     Document Type: Article

References (18)

1. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet 2012; 379: 953-964.
2. Esen F, Argun M, Pamukçu O, et al. Importance of N-terminal pro-brain natriuretic peptide in monitoring acute rheumatic carditis. Cardiol Young 2013; 28: 1-5.
3. Bucki R, Byfield FJ, Kulakowska A, et al. Extracellular gelsolin binds lipoteichoic acid and modulates cellular response to proinflammatory bacterial wall component. J Immunol 2008; 181: 4936-4944.
4. Wang H, Cheng B, Chen Q, et al. Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients. Crit Care 2008; 12: 1-6.
5. Lee PS, Drager LR, Stossel TP, Moore FD, Rogers SO. Relationship of plasma gelsolin levels to outcomes in critically ill surgical patients. Ann Surg 2006; 243: 399-403.
6. DiNubile MJ. Plasma gelsolin as a biomarker of inflammation. Arthritis Res Ther 2008; 10: 124.
7. Peddada N, Sagar A, Ashish GR, et al. Plasma gelsolin: a general prognostic marker of health. Med Hypotheses 2012; 78: 203-210.
8. Dajani AS, Ayoub E, Bierman FZ, et al. Guidelines for the diagnosis of rheumatic fever: Jones criteria, 1992 update. Special writing group of the committee on rheumatic fever, endocarditis, and Kawasaki disease of the council on cardiovascular disease in the young of the American Heart Association. JAMA 1992; 268: 2069-2073.
9. WHO. Rheumatic fever and rheumatic heart disease. World Health Organ Tech Rep Ser 2004; 923: 1-122.
10. Lee JF, Naguwa SM, Cheema GS, Gershwin ME. Acute rheumatic fever and its consequences: a persistent threat to developing nations in the 21st century. Autoimmun Rev 2009; 9: 117-123.
11. Guilherma L, Kalil J. Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease. J Clin Immunol 2010; 30: 17-23.
12. Narin N, Kütükçüler N, Ozyürek R, Bakiler AR, Parlar A, Arcasoy M. Lymphocyte subsets and plasma IL-1 alpha, IL-2, and TNF-alpha concentrations in acute rheumatic fever and chronic rheumatic heart disease. Clin Immunol Immunopathol 1995; 77: 172-176.
13. Kütükçüler N, Narin N. Plasma interleukin-7 (IL-7) and IL-8 concentrations in acute rheumatic fever and chronic rheumatic heart disease. Scand J Rheumatol 1995; 24: 383-385.
14. Haddad JG, Harper KD, Guoth M, Pietra GG, Sanger JW. Angiopathic consequences of saturating the plasma scavenger system for actin. Proc Natl Acad Sci USA 1990; 87: 1381-1385.
15. Erukhimov JA, Tang ZL, Johnson BA, et al. Actin-containing sera from patients with adult respiratory distress syndrome are toxic to sheep pulmonary endothelial cells. Am J Respir Crit Care Med 2000; 162: 288-294.
16. Cohen TS, Bucki R, Byfield FJ, et al. Therapeutic potential of plasma gelsolin administration in a rat model of sepsis. Cytokine 2011; 54: 235-238.
17. Osborn TM, Verdrengh M, Stossel TP, Tarkowski A, Bokarewa M. Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis. Arthritis Res Ther 2008; 10: R117.
18. Hu YL, Li H, Li WH, et al. The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation. Lupus 2013; 22: 1455-1461.